An expert opinion statement, addressing a critical gap in cardiac care for Duchenne muscular dystrophy – providing thorough recommendations for the initiation and titration of cardiac medications based on disease progression and patient response.
Partnership of cardiologists with gene transfer therapy prescribers is essential to identifing patient-specific considerations that might influence risk for adverse cardiac events.
Can early improvement after VAD implant positively affect outcomes? This study describes the clinical status of pediatric patients supported with a VAD and determines how clinical status at 1-month follow-up
Early Improvement in Clinical Status Following VAD Implantation in Children Read More »
"*" indicates required fields
Copyright © 2024 Advanced Cardiac Therapies Improving Outcomes Network
Notifications